Consolidated Condensed Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 28, 2015		Mar. 29, 2014
NET SALES	$ 95,855		$ 85,082
Cost of sales	72,516		66,981
GROSS PROFIT	23,339		18,101
Selling and administrative expenses	24,757		20,117
Other operating expense, net	490		152
Facility consolidation expenses	775		73
Impairment of assets	0	[1]	0
OPERATING LOSS	(2,683)		(2,241)
Interest expense	1,177		1,012
Other expense, net	10		10
Gain on purchase of business	0		(10,937)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE TAXES	(3,870)		7,674
Income tax provision (benefit)	(1,490)		2,854
INCOME (LOSS) FROM CONTINUING OPERATIONS	(2,380)		4,820
Loss from discontinued operations, net of tax	(88)		(192)
NET INCOME (LOSS)	$ (2,468)		$ 4,628
BASIC EARNINGS (LOSS) PER SHARE:
Continuing operations	$ (0.15)		$ 0.36
Discontinued operations	$ (0.01)		$ (0.02)
Net income (loss)	$ (0.16)		$ 0.34
BASIC SHARES OUTSTANDING	15,435	[2]	12,789	[2]
DILUTED EARNINGS (LOSS) PER SHARE:
Continuing operations	$ (0.15)		$ 0.36
Discontinued operations	$ (0.01)		$ (0.02)
Net income (loss)	$ (0.16)		$ 0.34
DILUTED SHARES OUTSTANDING	15,435	[2],[3]	13,017	[2],[3]
Dividends Per Share:
Common Stock	$ 0.00		$ 0.00
Class B Common Stock	$ 0.00		$ 0.00

[1] Asset impairments under these plans, when applicable, are classified as "loss on impairments" in the Company's Consolidated Condensed Statements of Operations.

[2] Includes Common and Class B Common shares, in thousands.

[3] Because their effects are anti-dilutive, shares issuable under stock option plans where the exercise price is greater than the average market price of the Company's Common Stock during the relevant period and directors' stock performance units have been excluded. Aggregate shares excluded for the three months ended March 28, 2015 and March 29, 2014 were 469 and 123, respectively.